Developer docs
API playgroundTry for free, no card

Search company profiles

smartpatient

Full company profile

uuid0004rjf

Namestring
smartpatient
Legal namestring
smartpatient GmbH
Websiteurl
smartpatient.eu
Company typeenum
Private
Founded yearint
2012
Descriptiontext

smartpatient GmbH, founded in 2012 and headquartered in Munich, operates the MyTherapy medication management platform — described as the world's most widely used medication management app with 12M+ users across 120+ countries and 30+ languages. The platform provides medication reminders, symptom and health data tracking, appointment management, care-team integration, and e-prescription connectivity, and is certified under ISO 13485, ISO 27001, GDPR, and HIPAA, enabling configuration of modules as regulated Software as a Medical Device (SaMD) under EU MDR and US FDA frameworks.

The company monetizes primarily B2B by licensing MyTherapy to pharmaceutical companies (top customers include Novartis, Merck KGaA, Novo Nordisk, Lilly, Daiichi Sankyo, ALK, UCB, Pfizer, Bayer, AstraZeneca, Sanofi, Boehringer Ingelheim, Sandoz, and Danone) to deploy configurable Patient Support Programs, Direct-to-Patient activation campaigns, and a Data & Insights analytics layer that combines MyTherapy patient behavior with Redcare Pharmacy prescription and dispensing data across ~25M patients. Pricing mixes annual SaaS-style enterprise licensing with pay-for-performance (outcome-based) components. In March 2025 the company launched Mighty, a conversational AI health assistant embedded in MyTherapy, and in March 2026 it extended its ecosystem via a strategic partnership with arztkonsultation to integrate telemedicine and guideline-based prescribing into the platform.

Since January 2021 smartpatient has operated as a subsidiary of Redcare Pharmacy (formerly Shop Apotheke Europe), Europe's leading online pharmacy, giving it structural advantages in e-prescription fulfillment (including a Gematik-approved CardLink NFC integration) and pharmacy distribution that standalone vendors cannot replicate. The 90-person team spans Munich and a Warsaw shared-services subsidiary (Smartpatient Business Services Sp. z o.o.).

Short descriptiontext

smartpatient GmbH operates MyTherapy, the world's most widely used medication management app with 12M+ users, licensing it B2B to pharmaceutical companies to deploy configurable patient support programs, direct-to-patient activation campaigns, and real-world data analytics across 120+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMunich, Germany
HQ citystring
Munich
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital health platform, patient support software, medication management, pharma patient engagement, real-world data analytics
Industry4 codes
PRIMARYHLALACAE
Chronic Condition Virtual Care & Disease Management (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLALAIAH
Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALABAL
Virtual Pharmacy & Medication Management Integration Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALAAAD
Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
NAICS code2 codes
  • Services for the Elderly and Persons with Disabilities624120
  • Offices of Physicians (except Mental Health Specialists)621111
SIC code2 codes
  • Services-Health Services8000
  • Services-Prepackaged Software7372
Product category
Digital Patient Engagement Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1B2B Enterprise Licensing to Pharma
TypeSubscription Recurring
Description

Pharmaceutical companies license the MyTherapy platform and configure customized patient support programs. Revenue is generated through platform licensing fees and program configuration services. The company offers performance-based models where payment is tied to predefined user actions, ensuring ROI for pharma partners.

smartpatient.eu
2Data & Insights Services
TypeData Monetisation
Description

Pharma partners access real-world patient data and insights generated from the platform, enabling evidence-driven strategic decisions around brand performance, patient behavior, and market dynamics.

smartpatient.eu
3Patient Activation Campaigns
TypeTransaction Fee
Description

Performance-based patient activation campaigns across MyTherapy and Redcare Pharmacy ecosystems, with pricing tied to predefined user actions and engagement outcomes.

smartpatient.eu
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1Free patient-facing app
ModelFreemiumBilling cadenceOthers
Notes

MyTherapy medication management app is free for patients, ensuring broad accessibility. Pharma partners configure branded patient support programs on top of the platform.

smartpatient.eu
2Enterprise B2B Platform Licensing
ModelSubscriptionBilling cadenceAnnual
Notes

Pharma partners subscribe to the MyTherapy platform to configure and deploy treatment-specific patient support programs. Pricing varies by scope, markets, and customization requirements.

smartpatient.eu
3Performance-based Campaigns
ModelOutcome Based/ PerformanceBilling cadencePay-as-you-go
Notes

Partners pay only for predefined user actions, ensuring every euro spent drives tangible results. Cost-efficient model where partners pay only for what they need, when they need it.

smartpatient.eu
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1MyTherapy
Description

The world's most widely used medication management app with over 12 million users. MyTherapy helps patients manage medications, track health data, and stay on top of treatment routines. The platform includes features such as medication reminders, symptom tracking, appointment management, and integration with pharmacies.

smartpatient.eu
+1 more record
Core offering1 text field

smartpatient develops and operates the MyTherapy platform, a medication management app used by over 12 million patients globally, which serves as digital infrastructure for pharmaceutical companies to deploy branded patient support programs, run direct-to-patient activation campaigns, and access real-world patient data and insights. The company licenses the platform to pharma partners, configures treatment-specific support modules, and integrates with Redcare Pharmacy's fulfillment network and telemedicine providers to deliver end-to-end digital care pathways.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • 85% higher adherence compared to baseline
+9 more records
Product overview1 text field

Smartpatient operates as a digital health ecosystem centered around the MyTherapy medication management platform (over 12 million users) and its parent company Redcare Pharmacy (Europe's leading online pharmacy). The offering is a platform-plus-modules architecture combining the core MyTherapy app with AI-powered patient support (Mighty), data analytics (Data & Insights), configurable patient support programs (PSP), and direct-to-patient marketing campaigns. The ecosystem integrates with telemedicine providers (arztkonsultation), pharmacy networks, and healthcare systems to deliver continuous patient support from diagnosis through treatment management.

Product and service6 records
1MyTherapy Platform
CategoryMedication Management Platform
Description

The world's most widely used medication management app with over 12 million users globally. It serves as the underlying platform that pharmaceutical partners license to deliver branded patient support, medication reminders, symptom tracking, appointment management, health data recording, and pharmacy connectivity.

2Mighty AI Health Assistant
CategoryAI Health Assistant
Description

Conversational AI health assistant embedded within MyTherapy, providing patients with real-time support for treatment-related questions, medication guidance, and access to verified health information. Facilitated over 50,000 patient interactions in its first year with 47% focused on health-related queries.

3Data & Insights Platform
CategoryData & Insights
Description

Real-world patient data and analytics solution combining MyTherapy user data with Redcare Pharmacy prescription and dispensing data across approximately 25 million patients. Offers sales benchmarking, behavioral pattern analysis, reasoning data, and AI-powered predictive insights to pharmaceutical partners.

4Patient Support Programs (PSP)
CategoryPatient Support Services
Description

Configurable digital patient support programs built on the MyTherapy platform, enabling pharma partners to deploy branded, treatment-specific support including automated regimen and titration scheduling, gamification, injection site tracking, custom educational content, SaMD modules, and care team connectivity.

5Patient Activation Campaigns
CategoryPatient Activation Services
Description

Direct-to-patient marketing campaigns enabling pharma to reach, educate, and activate patients with targeted, compliant campaigns across the combined MyTherapy and Redcare Pharmacy platform of 25M+ patients. Features precision targeting, behavioral science techniques, and performance-based pricing tied to predefined user actions.

6E-Prescription Integration
CategoryE-Prescription Services
Description

Electronic prescription functionality enabling patients to retrieve e-prescriptions via NFC-enabled health insurance card (CardLink via Gematik) and order medications for home delivery through Redcare Pharmacy directly from MyTherapy.

Scale indicator17 records

Each record includes

Type, Value, Description, Source

Partnership18 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-05
Description

Strategic partnership to establish an integrated digital care pathway launching initially in clinical obesity. Combines MyTherapy's patient activation and medication management platform with arztkonsultation's telemedicine infrastructure. Aims to reduce time-to-diagnosis, shorten specialist waiting times, improve medication adherence, and create scalable model for additional chronic disease areas. The partnership is designed as indication-agnostic and expandable.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-26
Description

Collaboration to develop a digital support module within MyTherapy app for Nustendi patients with high LDL cholesterol levels (hypercholesterolemia). The module incorporates reminders, motivational prompts, health data trackers, and lifestyle tips to improve treatment adherence and reduce cardiovascular risk events such as heart attack and stroke.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-04
Description

Three-year collaboration to improve treatment adherence in allergy immunotherapy through digital patient support programs built on MyTherapy. Programs have shown high patient engagement with 95% understanding the importance of long-term therapy and over 90% feeling well educated. Partnership supports thousands of allergy patients across Europe.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-14
Description

Expanded strategic partnership with Merck KGaA, Darmstadt, Germany spanning more than 5 years across multiple therapeutic areas. Programs operate across five continents. Includes MS digital companion and new cardiovascular disease digital companion. Features remote monitoring and SaMD extensions. Extended from specialty care to primary care setting.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

smartpatient was acquired by Redcare Pharmacy in January 2021. This partnership marked a key milestone enabling holistic patient-centric experience connecting e-prescription, fulfillment, and ongoing digital support within one seamless ecosystem. Redcare Pharmacy is Europe's leading online pharmacy.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Partnership with Novartis dates back to 2018, making it one of the longest-standing collaborations. Companies have worked closely on developing impactful patient support solutions so patients on Novartis medicines have support to better manage their conditions. Global Patient Solutions and Services leadership involved.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pioneering digital support program for people living with obesity in Germany. Smartpatient and Novo Nordisk introduced a digital support model for obesity care, combining patient activation with medication management support.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Obesity program collaboration with Lilly scaling patient-centric digital health solutions. Partnership marks one year of collaboration with demonstrated impact.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership leveraging digital health solutions to make patient support more accessible for patients living with severe diseases. Head of Immunology Germany leads collaboration for Germany market.

10Boehringer Ingelheim
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Logo listed as trusted pharma partner.

smartpatient.eu
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Logo listed as trusted pharma partner.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Logo listed as trusted pharma partner.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Logo listed as trusted pharma partner.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Logo listed as trusted pharma partner.

15Sandoz
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Logo listed as trusted pharma partner.

smartpatient.eu
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration bringing patients closer to nutritional therapy support through MyTherapy. Gains valuable insights into patient needs and challenges for more targeted and personalized support in nutritional therapy.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Logo listed as trusted pharma partner.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership for advancing breast and prostate cancer patient support through MyTherapy platform.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key highlights2 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers15 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

smartpatient

Digital Patient Engagement Softwaresmartpatient.eu

smartpatient GmbH operates MyTherapy, the world's most widely used medication management app with 12M+ users, licensing it B2B to pharmaceutical companies to deploy configurable patient support programs, direct-to-patient activation campaigns, and real-world data analytics across 120+ countries.

What smartpatient does

smartpatient GmbH, founded in 2012 and headquartered in Munich, operates the MyTherapy medication management platform — described as the world's most widely used medication management app with 12M+ users across 120+ countries and 30+ languages. The platform provides medication reminders, symptom and health data tracking, appointment management, care-team integration, and e-prescription connectivity, and is certified under ISO 13485, ISO 27001, GDPR, and HIPAA, enabling configuration of modules as regulated Software as a Medical Device (SaMD) under EU MDR and US FDA frameworks.

The company monetizes primarily B2B by licensing MyTherapy to pharmaceutical companies (top customers include Novartis, Merck KGaA, Novo Nordisk, Lilly, Daiichi Sankyo, ALK, UCB, Pfizer, Bayer, AstraZeneca, Sanofi, Boehringer Ingelheim, Sandoz, and Danone) to deploy configurable Patient Support Programs, Direct-to-Patient activation campaigns, and a Data & Insights analytics layer that combines MyTherapy patient behavior with Redcare Pharmacy prescription and dispensing data across ~25M patients. Pricing mixes annual SaaS-style enterprise licensing with pay-for-performance (outcome-based) components. In March 2025 the company launched Mighty, a conversational AI health assistant embedded in MyTherapy, and in March 2026 it extended its ecosystem via a strategic partnership with arztkonsultation to integrate telemedicine and guideline-based prescribing into the platform.

Since January 2021 smartpatient has operated as a subsidiary of Redcare Pharmacy (formerly Shop Apotheke Europe), Europe's leading online pharmacy, giving it structural advantages in e-prescription fulfillment (including a Gematik-approved CardLink NFC integration) and pharmacy distribution that standalone vendors cannot replicate. The 90-person team spans Munich and a Warsaw shared-services subsidiary (Smartpatient Business Services Sp. z o.o.).

smartpatient firmographics

Firmographics
Name
smartpatient
Legal name
smartpatient GmbH
Website
https://smartpatient.eu
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
smartpatient GmbH operates MyTherapy, the world's most widely used medication management app with 12M+ users, licensing it B2B to pharmaceutical companies to deploy configurable patient support programs, direct-to-patient activation campaigns, and real-world data analytics across 120+ countries.
Ownership category
akta.pro rank

smartpatient industry classification

Industry
Product category
Digital Patient Engagement Software
NAICS
Services for the Elderly and Persons with Disabilities (624120), Offices of Physicians (except Mental Health Specialists) (621111)
SIC
Services-Health Services (8000), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLALACAE
Chronic Condition Virtual Care & Disease Management (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLALAIAH
Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLALABAL
Virtual Pharmacy & Medication Management Integration Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALAAAD
Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

Keywords

  • Digital health platform
  • Patient support software
  • Medication management
  • Pharma patient engagement
  • Real-world data analytics

Where smartpatient is headquartered

Location

Headquarters

HQ city
Munich
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

smartpatient business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. B2B Enterprise Licensing to Pharma: Pharmaceutical companies license the MyTherapy platform and configure customized patient support programs. Revenue is generated through platform licensing fees and program configuration services. The company offers performance-based models where payment is tied to predefined user actions, ensuring ROI for pharma partners.
  2. Data & Insights Services: Pharma partners access real-world patient data and insights generated from the platform, enabling evidence-driven strategic decisions around brand performance, patient behavior, and market dynamics.
  3. Patient Activation Campaigns: Performance-based patient activation campaigns across MyTherapy and Redcare Pharmacy ecosystems, with pricing tied to predefined user actions and engagement outcomes.

Pricing tiers

ModelBillingPrice
FreemiumOthersFree patient-facing app
SubscriptionAnnualEnterprise B2B Platform Licensing
Outcome Based/ PerformancePay-as-you-goPerformance-based Campaigns

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

smartpatient product offering

Product offering

Core offering

smartpatient develops and operates the MyTherapy platform, a medication management app used by over 12 million patients globally, which serves as digital infrastructure for pharmaceutical companies to deploy branded patient support programs, run direct-to-patient activation campaigns, and access real-world patient data and insights. The company licenses the platform to pharma partners, configures treatment-specific support modules, and integrates with Redcare Pharmacy's fulfillment network and telemedicine providers to deliver end-to-end digital care pathways.

Product overview

Smartpatient operates as a digital health ecosystem centered around the MyTherapy medication management platform (over 12 million users) and its parent company Redcare Pharmacy (Europe's leading online pharmacy). The offering is a platform-plus-modules architecture combining the core MyTherapy app with AI-powered patient support (Mighty), data analytics (Data & Insights), configurable patient support programs (PSP), and direct-to-patient marketing campaigns. The ecosystem integrates with telemedicine providers (arztkonsultation), pharmacy networks, and healthcare systems to deliver continuous patient support from diagnosis through treatment management.

Differentiator

Problem solved

Functional benefit

Brands

  • MyTherapy: The world's most widely used medication management app with over 12 million users. MyTherapy helps patients manage medications, track health data, and stay on top of treatment routines. The platform includes features such as medication reminders, symptom tracking, appointment management, and integration with pharmacies.
  • Mighty

Products and services

  • MyTherapy Platform The world's most widely used medication management app with over 12 million users globally. It serves as the underlying platform that pharmaceutical partners license to deliver branded patient support, medication reminders, symptom tracking, appointment management, health data recording, and pharmacy connectivity.
  • Mighty AI Health Assistant Conversational AI health assistant embedded within MyTherapy, providing patients with real-time support for treatment-related questions, medication guidance, and access to verified health information. Facilitated over 50,000 patient interactions in its first year with 47% focused on health-related queries.
  • Data & Insights Platform Real-world patient data and analytics solution combining MyTherapy user data with Redcare Pharmacy prescription and dispensing data across approximately 25 million patients. Offers sales benchmarking, behavioral pattern analysis, reasoning data, and AI-powered predictive insights to pharmaceutical partners.
  • Patient Support Programs (PSP) Configurable digital patient support programs built on the MyTherapy platform, enabling pharma partners to deploy branded, treatment-specific support including automated regimen and titration scheduling, gamification, injection site tracking, custom educational content, SaMD modules, and care team connectivity.
  • Patient Activation Campaigns Direct-to-patient marketing campaigns enabling pharma to reach, educate, and activate patients with targeted, compliant campaigns across the combined MyTherapy and Redcare Pharmacy platform of 25M+ patients. Features precision targeting, behavioral science techniques, and performance-based pricing tied to predefined user actions.
  • E-Prescription Integration Electronic prescription functionality enabling patients to retrieve e-prescriptions via NFC-enabled health insurance card (CardLink via Gematik) and order medications for home delivery through Redcare Pharmacy directly from MyTherapy.

Quantifiable outcome

  • 85% higher adherence compared to baseline
  • +9 more outcomes

Companies that use smartpatient

Customer profile

Named customers15 records

Segments4 records

Ideal customer profiles2 records

smartpatient technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature6 records

smartpatient partnerships and signals

Strategic signal

Partnerships

18 partnerships are on record, tiered core and minor.

  • arztkonsultationcoreStrategic or Co-development Partner · 5 March 2026Strategic partnership to establish an integrated digital care pathway launching initially in clinical obesity. Combines MyTherapy's patient activation and medication management platform with arztkonsultation's telemedicine infrastructure. Aims to reduce time-to-diagnosis, shorten specialist waiting times, improve medication adherence, and create scalable model for additional chronic disease areas. The partnership is designed as indication-agnostic and expandable.
  • Daiichi SankyocoreStrategic or Co-development Partner · 26 November 2025Collaboration to develop a digital support module within MyTherapy app for Nustendi patients with high LDL cholesterol levels (hypercholesterolemia). The module incorporates reminders, motivational prompts, health data trackers, and lifestyle tips to improve treatment adherence and reduce cardiovascular risk events such as heart attack and stroke.
  • ALKcoreStrategic or Co-development Partner · 4 November 2025Three-year collaboration to improve treatment adherence in allergy immunotherapy through digital patient support programs built on MyTherapy. Programs have shown high patient engagement with 95% understanding the importance of long-term therapy and over 90% feeling well educated. Partnership supports thousands of allergy patients across Europe.
  • Merck KGaAcoreStrategic or Co-development Partner · 14 February 2024Expanded strategic partnership with Merck KGaA, Darmstadt, Germany spanning more than 5 years across multiple therapeutic areas. Programs operate across five continents. Includes MS digital companion and new cardiovascular disease digital companion. Features remote monitoring and SaMD extensions. Extended from specialty care to primary care setting.
  • Redcare Pharmacy (formerly Shop Apotheke Europe)coreStrategic or Co-development Partner · 1 January 2021smartpatient was acquired by Redcare Pharmacy in January 2021. This partnership marked a key milestone enabling holistic patient-centric experience connecting e-prescription, fulfillment, and ongoing digital support within one seamless ecosystem. Redcare Pharmacy is Europe's leading online pharmacy.
  • NovartiscoreStrategic or Co-development Partner · 1 January 2018Partnership with Novartis dates back to 2018, making it one of the longest-standing collaborations. Companies have worked closely on developing impactful patient support solutions so patients on Novartis medicines have support to better manage their conditions. Global Patient Solutions and Services leadership involved.
  • Novo NordiskcoreStrategic or Co-development PartnerPioneering digital support program for people living with obesity in Germany. Smartpatient and Novo Nordisk introduced a digital support model for obesity care, combining patient activation with medication management support.
  • LillycoreStrategic or Co-development PartnerObesity program collaboration with Lilly scaling patient-centric digital health solutions. Partnership marks one year of collaboration with demonstrated impact.
  • UCBcoreStrategic or Co-development PartnerPartnership leveraging digital health solutions to make patient support more accessible for patients living with severe diseases. Head of Immunology Germany leads collaboration for Germany market.
  • Boehringer IngelheimminorStrategic or Co-development PartnerLogo listed as trusted pharma partner.
  • PfizerminorStrategic or Co-development PartnerLogo listed as trusted pharma partner.
  • AstraZenecaminorStrategic or Co-development PartnerLogo listed as trusted pharma partner.
  • BayerminorStrategic or Co-development PartnerLogo listed as trusted pharma partner.
  • SanofiminorStrategic or Co-development PartnerLogo listed as trusted pharma partner.
  • SandozminorStrategic or Co-development PartnerLogo listed as trusted pharma partner.
  • DanoneminorStrategic or Co-development PartnerCollaboration bringing patients closer to nutritional therapy support through MyTherapy. Gains valuable insights into patient needs and challenges for more targeted and personalized support in nutritional therapy.
  • Berlin-ChemieminorStrategic or Co-development PartnerLogo listed as trusted pharma partner.
  • Cancer Support CommunityminorStrategic or Co-development PartnerPartnership for advancing breast and prostate cancer patient support through MyTherapy platform.

Scale indicators17 records

Recent moves7 records

Expansion highlights5 records

smartpatient competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key highlights2 records

Customer concentration

smartpatient social profiles

Digital presence

smartpatient compliance and trust

Trust signal

Compliance4 records

smartpatient financial estimates

Financial estimate

Revenue estimate

Valuation estimate

smartpatient leadership team

Management profile

Number of profiles

Profiles9 records

smartpatient subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

smartpatient funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

smartpatient M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about smartpatient

What does smartpatient do?

smartpatient develops and operates the MyTherapy platform, a medication management app used by over 12 million patients globally, which serves as digital infrastructure for pharmaceutical companies to deploy branded patient support programs, run direct-to-patient activation campaigns, and access real-world patient data and insights. The company licenses the platform to pharma partners, configures treatment-specific support modules, and integrates with Redcare Pharmacy's fulfillment network and telemedicine providers to deliver end-to-end digital care pathways.

Is smartpatient a public or private company?

smartpatient is a private company. It is classified as corporate owned and is currently operating.

When was smartpatient founded?

smartpatient was founded in 2012. It employs 51 to 100 people.

Where is smartpatient based?

smartpatient is headquartered in Munich, Germany, in the Europe region.

How does smartpatient make money?

Three revenue lines are on record. B2B Enterprise Licensing to Pharma is the primary driver. The others are data & Insights Services and patient Activation Campaigns.

Does smartpatient have an API?

No public API is recorded for smartpatient.

What industry is smartpatient in?

smartpatient's product category is Digital Patient Engagement Software. Its primary akta.pro industry code is HLALACAE, Chronic Condition Virtual Care & Disease Management (Payer-Sponsored), with a secondary code of HLALAIAH, Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing. Its NAICS code is 624120 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall StDevice Partnership Might Change The Case For Investing In Ypsomed (SWX:YPSN)Ypsomed announced a partnership with smartpatient linking its SmartPilot injection support to the MyTherapy digital patient engagement platform. The tie-up aims to embed connected devices into pharma support programs, potentially increasing stickiness for self-injection platforms. The partnership does not materially change near-term operational risks, with capacity expansion and EBIT margins remaining key factors.EIN PresswireSmartpatient and Novo Nordisk Expand Patient Support Partnership Across Additional Treatment FormatsSmartpatient and Novo Nordisk expanded their patient support partnership in Germany to include an additional treatment format, building on a digital obesity care program launched in 2025 and extended to Type 2 diabetes in early 2026. The expansion aims to provide consistent support across treatment formats as options evolve.EIN PresswireSmartpatient und Novo Nordisk erweitern ihre Partnerschaft zur digitalen Patientenbegleitung auf weitere TherapieformenSmartpatient and Novo Nordisk expanded their digital patient support partnership in Germany to include additional therapy forms, building on a program launched in 2025 for obesity and expanded to type 2 diabetes in early 2026. The expansion aims to provide consistent digital support across different treatment options, with executives citing the need to adapt to new therapy innovations.EIN PresswireSmartpatient und Novo Nordisk setzen neue Maßstäbe für vernetzte Versorgung bei Stoffwechselerkrankungen in DeutschlandSmartpatient and Novo Nordisk launched a digital program in Germany to support Type-2 diabetes patients, expanding their Direct-to-Patient model. The program uses MyTherapy, a medication management app with over 12 million users, to provide personalized onboarding, therapy guidance, and symptom documentation. The collaboration aims to improve long-term treatment adherence and patient self-management.EIN PresswireSmartpatient and Novo Nordisk Set a New Standard for Connected Care for People with Metabolic Diseases in GermanySmartpatient and Novo Nordisk launched a new digital support program for Type 2 diabetes in Germany, expanding their direct-to-patient model from obesity care. The program, delivered via MyTherapy with over 12 million users, provides personalized onboarding, treatment guidance, and refill support. The collaboration aims to improve long-term treatment engagement and continuity.EIN PresswireSmartpatient und Cancer Support Community kooperieren, um die Unterstützung bei Brust- und Prostatakrebs zu verbessernsmartpatient and Cancer Support Community announced a partnership to integrate cancer support resources into the MyTherapy app for breast and prostate cancer patients. The collaboration brings the 'Frankly Speaking About Cancer' series and CSC's helpline to the platform, aiming to provide personalized psychosocial support. CSC has already supported over 617,000 cancer patients.EIN PresswireSmartpatient and Cancer Support Community Partner for Advancing Breast and Prostate Cancer SupportSmartpatient and Cancer Support Community announced a partnership to embed CSC's educational series and helpline into the MyTherapy platform for breast and prostate cancer patients. CSC has served over 617,000 cancer patients, and the partnership aims to provide continuous psychosocial support within the app's ecosystem.EIN PresswireSmartpatient Marks One Year of Mighty, Expanding Its AI Health Assistant Through New PartnershipsSmartpatient, a digital health company and subsidiary of Redcare Pharmacy, is marking one year of its AI health assistant "Mighty" within the MyTherapy medication management platform, which now serves over 12 million patients globally. Since its March 2025 launch, Mighty has facilitated more than 50,000 patient conversations, with 47% being health-related queries about treatment routines and medication management. The company is expanding the assistant through new partnerships as part of its strategy to position conversational AI within trusted direct-to-patient ecosystems for pharmaceutical industry engagement.EIN PresswireSmartpatient blickt auf ein Jahr Mighty zurück und erweitert seinen KI-Gesundheitsassistenten durch neue Partnerschaftensmartpatient, the Digital-Health company behind the MyTherapy medication management platform, marked one year of its AI health assistant "Mighty" and announced plans to expand the tool through new partnerships. Since its launch in March 2025, Mighty has facilitated more than 50,000 patient interactions, with 47 percent having a health-related focus, supporting users in navigating therapy routines and verifying health information. The company, a subsidiary of Redcare Pharmacy, positions MyTherapy as digital infrastructure for scalable Direct-to-Patient programs targeting pharmaceutical partners.EIN PresswireSmartpatient and Daiichi Sankyo Join Forces to Improve Treatment Adherence in HypercholesterolemiaSmartpatient and Daiichi Sankyo have launched a joint digital health program to support patients with hypercholesterolemia, introducing a therapy-specific module within the MyTherapy app for patients prescribed Nustendi\u00ae. The module combines medication reminders, motivational prompts, health data trackers, and lifestyle tips to improve treatment adherence and reduce cardiovascular risk. Both companies, headquartered in Munich, Germany, plan to expand their collaboration over the coming months with additional digital features and real-world insights.